SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Baxter International, Inc. (BAX)

NEW YORK, April 19, 2017 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Baxter International, Inc. ("Baxter" or the "Company") (NYSE: BAX). Such investors are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/bax.

On April 14, 2017, Baxter revealed that an employee had received a grand jury subpoena regarding the Antitrust Division of the U.S. Department of Justice's criminal investigation into Baxter's sales practices in relation to an intravenous saline. Following this news, Baxter stock dropped $0.43 per share, or 0.81%, to close at $52.82 on April 17, 2017. 

If you are aware of any facts relating to this investigation, or purchased shares of Baxter, you can assist this investigation by visiting the firm's site: www.bgandg.com/bax. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484. 

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients.  In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | [email protected]

SOURCE Bronstein, Gewirtz & Grossman, LLC

Related Links

http://www.bgandg.com